PRMT5 and acute myeloid leukemia: In acute myeloid leukemia (AML), PRMT5 silences miR‐29b expression by H4R3me2, which leads to upregulation of transcription factor “Specificity protein 1” (SP1) and activation of the “Fms‐like tyrosine kinase 3” (FLT3).92